Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.

Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (2006) 2.01

Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol (2010) 1.29

Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed) (2012) 1.28

Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci U S A (1996) 1.19

The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition. Blood (2010) 1.18

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem J (2001) 1.14

The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (1994) 1.08

AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis. J Neurosci (2009) 0.97

Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants. Blood (2005) 0.91

A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neonatal Med (2008) 0.90

The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding. Protein Sci (1997) 0.90

A family of diverse Kunitz inhibitors from Echinococcus granulosus potentially involved in host-parasite cross-talk. PLoS One (2009) 0.89

How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol (2015) 0.87

Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor. J Biochem (2010) 0.87

Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med (2008) 0.86

Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2013) 0.84

Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor. Biochem J (1997) 0.82

Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice. J Clin Invest (2000) 0.81

Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). J Biol Chem (2013) 0.81

Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor. Biochem J (2012) 0.81

Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa. J Biol Chem (2013) 0.79

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood (2014) 0.78

Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder. J Clin Invest (2013) 0.77

Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. J Biol Chem (2011) 0.76

Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins. Br J Haematol (2016) 0.75

Factor XI activation in a revised model of blood coagulation. Science (1991) 2.87

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem (1988) 2.09

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature (1989) 2.07

A proenzyme form of human urokinase. J Biol Chem (1982) 1.98

Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood (1997) 1.94

The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem (1980) 1.89

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J (1990) 1.87

cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J Biol Chem (1987) 1.79

Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood (1988) 1.72

Purification and properties of human coagulation factor VII. J Biol Chem (1980) 1.61

Binding of human factor VII and VIIa to monocytes. J Clin Invest (1982) 1.60

Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science (1990) 1.56

Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci U S A (1998) 1.55

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem (1990) 1.52

Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood (1996) 1.50

A murine model of factor XI deficiency. Blood Coagul Fibrinolysis (1997) 1.49

Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47

Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation (1991) 1.47

Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood (1992) 1.46

Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem (1998) 1.46

Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem (1989) 1.45

Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43

The protein Z-dependent protease inhibitor is a serpin. Biochemistry (1999) 1.41

Characterization of the protein Z-dependent protease inhibitor. Blood (2000) 1.41

Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood (1996) 1.39

Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37

Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res (1989) 1.37

Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost (2001) 1.36

Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation (2001) 1.35

A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost (2001) 1.33

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood (2001) 1.30

Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem (2000) 1.29

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem (1992) 1.29

Human Protein Z. J Clin Invest (1984) 1.28

The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood (1992) 1.22

Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A (2000) 1.21

Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab Invest (1989) 1.19

Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood (1991) 1.17

Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A (1997) 1.17

Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis (1989) 1.15

Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem (1990) 1.11

Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood (1987) 1.11

Characterization of the inhibition of tissue factor in serum. Blood (1987) 1.10

Comparison of cell-surface TFPIalpha and beta. J Thromb Haemost (2005) 1.09

Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrinolysis (1993) 1.08

Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J Biol Chem (1988) 1.08

Purification of human brain tissue factor. J Biol Chem (1985) 1.08

The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (1994) 1.08

Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells. J Biol Chem (1990) 1.05

Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A (1987) 1.02

N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line. Biochemistry (1989) 1.02

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost (2004) 1.01

Secretion of active kringle-2-serine protease in Escherichia coli. Biochemistry (1990) 1.00

Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry (1994) 0.99

Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock (1994) 0.99

Human coagulation factor Va is a cofactor for the activation of protein C. Proc Natl Acad Sci U S A (1983) 0.99

Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res (1999) 0.98

Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A (1990) 0.98

Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem (1988) 0.97

Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity. Thromb Haemost (1998) 0.96

Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. J Clin Invest (1999) 0.95

Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits. Thromb Haemost (1992) 0.95

Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients. J Thromb Haemost (2009) 0.95

The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood (1984) 0.94

Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo. J Biol Chem (1995) 0.93

Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Blood (1993) 0.93

The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. J Clin Invest (1995) 0.93

The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin. J Biol Chem (1983) 0.93

Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis (1993) 0.91

Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin. J Biol Chem (1991) 0.90

Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol (1989) 0.90

The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha. J Biol Chem (1992) 0.90

Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood (1990) 0.89

Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest (1985) 0.89

The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va. J Thromb Haemost (2012) 0.89

An inhibitor of plasminogen activation from human placenta. Purification and characterization. J Biol Chem (1987) 0.88

Evolution of human von Willebrand factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand antigen II. Biochem Biophys Res Commun (1987) 0.88

cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell. FEBS Lett (1987) 0.88

Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators. Thromb Haemost (1985) 0.87

Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J (1997) 0.86

Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost (2003) 0.86

Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost (2006) 0.86

Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. J Biol Chem (1989) 0.86

Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. J Biol Chem (1991) 0.85

Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood (1993) 0.84

Evidence of clinically significant extravascular stores of factor IX. J Thromb Haemost (2013) 0.83

Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes. J Biol Chem (1997) 0.83

Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor. Biochem J (1997) 0.82

Tissue factor pathway inhibitor. Methods Enzymol (1993) 0.82

Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. Blood (1987) 0.81

Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity. Thromb Haemost (1998) 0.81

Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science (1990) 0.81

Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem (1996) 0.81

Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Arterioscler Thromb Vasc Biol (1999) 0.81

Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Thromb Res (1991) 0.81

Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem (1985) 0.80